UNSPSC 85521657: Replacement of hemiazygos vein with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of hemiazygos vein with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05R107Z

UNSPSC 85521657, Replacement of hemiazygos vein with autologous tissue substitute, open approach, is a Commodity code that shows little relevant recent state and local procurement activity. The code nominally describes a specific surgical procedure, yet the recent opportunities posted under this classification do not involve vascular surgery or tissue substitution. Instead, they span independent medical evaluations for pension disability determinations, surgical benefit carve-outs for Centers of Excellence networks, occupational medical surveillance, specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which align with the code's stated surgical scope. The mismatch suggests either miscoding by the issuing bodies or a data classification error within the system.

The source records six recent state and local opportunities tagged to this code across Arizona, California, Washington, Texas, and Florida, but none involve the vascular procedure the code nominally describes. The City of Phoenix Retirement Office issued an RFP for independent medical evaluation services due October 16, 2026; the City of Long Beach issued an RFP for surgical benefit management due October 7, 2026; the Washington State Department of Transportation issued an RFP for occupational medical surveillance due October 9, 2026; and other health system and county entities solicited pharmacy, staffing, and specialty care services. This code does not appear to support active procurement of the procedure it names, and prospective vendors should verify coding accuracy with issuing bodies before pursuing opportunities listed under this classification.